Search clinical trials for: Tarceva (OSI-774)
Total 1820 results
-
M.D. Anderson Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompletedHead and Neck CancerUnited States
-
OSI PharmaceuticalsTerminatedRecurrent or Refractory Pediatric EpendymomaUnited States, Canada, United Kingdom
-
M.D. Anderson Cancer CenterCompleted
-
National Cancer Institute (NCI)CompletedLung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Adenosquamous Lung Carcinoma | Bronchioloalveolar Carcinoma | Large Cell Lung Carcinoma | Squamous Cell Lung CarcinomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
OSI PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States, United Kingdom
-
National Cancer Institute (NCI)CompletedHilar Cholangiocarcinoma | Recurrent Gallbladder Carcinoma | Unresectable Extrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Gallbladder Adenocarcinoma | Recurrent Extrahepatic Bile Duct Carcinoma | Extrahepatic Bile Duct Adenocarcinoma | Gallbladder Adenocarcinoma With Squamous... and other conditionsUnited States
-
M.D. Anderson Cancer CenterWithdrawnAdvanced Cancers
-
M.D. Anderson Cancer CenterNovartis; OSI PharmaceuticalsCompletedHead And Neck CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
National Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7United States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)TerminatedHIV Infection | Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Pharmacosmos A/SBioStataCompletedAnaemia in Chronic Kidney DiseaseSweden, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
M.D. Anderson Cancer CenterNovartis; OSI PharmaceuticalsTerminatedPancreatic CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
Pharmacosmos A/SBioStataCompletedSevere Postpartum HaemorrhageDenmark
-
M.D. Anderson Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedNon-Small Cell Lung Cancer | Lung CancerUnited States
-
OSI PharmaceuticalsCompleted
-
Heather WakeleeNovartis; Genentech, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC), Recurrent | Non-small Cell Lung Cancer (NSCLC), Stage IVUnited States
-
SCRI Development Innovations, LLCAstraZeneca; Genentech, Inc.CompletedKidney CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; University of ChicagoCompletedMesotheliomaUnited States
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedUrea Cycle DisordersUnited States
-
M.D. Anderson Cancer CenterAstellas Pharma Inc; The Kadoorie Charitable FoundationsRecruiting
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | CirrhosisUnited States
-
Nathan Pennell, MD, PhDNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminatedBrain Cancer | Glioblastoma MultiformeUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Withdrawn
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
University of Wisconsin, MadisonPfizer; Genentech, Inc.Completed
-
Groupe Francophone des MyelodysplasiesRoche Pharma AGCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-small Cell Lung Cancer | Adenocarcinoma of the LungUnited States
-
Duke UniversityGenentech, Inc.; OSI PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
National Cancer Institute (NCI)TerminatedBladder Carcinoma | Recurrent Bladder CarcinomaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; OSI PharmaceuticalsCompletedLiver CancerUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompletedPancreatic Cancer | Pancreatic AdenocarcinomaUnited States
-
The University of Texas Health Science Center at...National Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterGenentech, Inc.; Vanderbilt-Ingram Cancer CenterCompletedLung CancerUnited States
-
NYU Langone HealthBayer; OSI PharmaceuticalsCompletedPancreatic CancerUnited States
-
Genentech, Inc.CompletedColorectal CancerUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
University of ChicagoNational Cancer Institute (NCI)CompletedMalignant Peritoneal MesotheliomaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedHepatocellular Carcinoma | Liver CancerUnited States
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand